Additional Details

  • Better Breathers Support Group | Hybrid

    MyMichigan Medical Center | 2660 W. Sugnet Road
    Midland MI. 48670
    View Details

  • Every Breath Forward Support Group | Hybrid

    UK Healthcare - Turfland (Room 2123) | 2195 Harrodsburg Rd
    Lexington KY. 40504
    View Details

  • Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With Idiopathic Pulmonary Fibrosis

    Trial Management Group Inc
    Windsor ON. N8X1T3
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Critical Care Pulmonary and Sleep Associates (Ccpsa) - West Clinic
    Lakewood CO. 80228
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Meris Clinical Research
    Brandon FL. 33511
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Newportnativemd, Inc.
    Newport Beach CA. 92663-3600
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Hannibal Regional Hospital
    Hannibal MO. 63401
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Coastal Pulmonary & Critical Care, PLC
    St. Petersburg FL. 33704-2733
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Palmtree Clinical Research
    Palm Springs CA. 92262
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Paradigm Clinical Research Centers, Inc. - Redding
    Redding CA. 96001
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Anmed Medical Center
    Anderson SC. 29621
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Clinical Research Associates of Central, PA, LLC
    DuBois PA. 15801
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Horizon Clinical Research Group
    Cypress TX. 77429
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Pulmonary Specialists of The Palm Beaches
    Loxahatchee Groves FL. 33470
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Clinical Research of Gastonia (CRG)
    Gastonia NC. 28054
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Elevate Clinical Research
    Houston TX. 77058
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    El Paso Pulmonary Association, PA
    El Paso TX. 79902
    View Details

  • Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets

    Clinical Research and Associates, Inc.
    Miami FL. 33126
    View Details

  • Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

    National Institutes of Health Clinical Center
    Bethesda MD. 20892
    View Details